RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 AVP-825 Produces Effective, Well-Tolerated Migraine Relief
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 9
SP 8
OP 9
DO 10.1177/1559897715588283
UL http://mdc.sagepub.com/content/15/9/8.abstract
AB AVP-825 is a product containing a low-dose powder form of sumatriptan that can be delivered intranasally to treat migraines. It is better tolerated than higher doses of oral sumatriptan and has a faster onset of action. A pooled analysis of 2 studies confirmed that AVP-825 confers rapid headache relief sustained over 48 hours.